These medications , Semaglutide and Wegovy, represent a groundbreaking shift in approaches to treating metabolic disorders and, increasingly, weight management . They operate as GLP-1 receptor agonists , https://bookmark-dofollow.com/story29772580/copyright-semaglutide-understanding-the-the-glp-1-movement